January 2025: GVS took part in the 2050 Environment Conference at the Hilton Hotel in Tel Aviv.

Aug-2024: GVS hosted and participated in a joint seminar on public health risks mitigation using GVS’ BioChem sensing systems, at GVS HQ offices with colleagues from BGU

April-2024: GVS hosted and participated in a products security seminar, using HyperEye-FRN system, at GVS HQ offices with colleagues from BGU

February 2024: GVS participated in a biothreats detection and intensification seminar using HyperEye-AP [BDC] and HyperEye-CPD systems, in Fairfax County, USA.

June 5th 2023- GVS attended a pitch session with CONCAMIN (the Confederation of Industrial Chambers of Mexico).

November 2nd 2022: GVS attended the exclusive business Forum with the CEO and President of Fairfax County EDA

June 8th 2022: GVS attended a business-networking forum about U.S. market opportunities - Smart City and Infrastructure Security

2020-2021: GVS successfully completed validation tests with Rambam Health Care Campus, testing personnel to enable identifying Cov-Sars-II infected persons, as good as RT-PCR.

Sep-2021: GVS received Israeli (AMAR) MoH approval (Stage-I) to continue test and expand the uses of GVS' HyperEye-CPD systems at filed.

2016-2020: GVS successfully completed validation tests and commercial projects with several Environmental protection embodies. Tracking the ambient air quality and monitoring in near real-time the PM10/PM2.5 pollution sources apportionment across time and locations. We received seal of excellent from Horizon 2020 and were selected as the innovative and rapid solution by both public and governmental embodies. We shared our quince health care solution to WHO for outdoor/indoor air quality control also during COP26 Glasgow events.

2018-2021 GVS and its partners are working on the Urban air pollution monitoring, food safety and HLS arena, and keeping facilities safe (health wise).